Are you looking to stay current with all of the latest Pulmonology news articles and research? Look no further! MDLinx Pulmonology medical editors extensively research respiratory medical journals to find the most beneficial Pulmonology clinical literature. Topics range from: Pediatric Pulmonology, Sleep Disorders, Asthma, COPD, Cystic Fibrosis and much more. In a matter of minutes, Pulmonologists and their staff can stay up to date with the most current published information.
On this page, you'll also find MDLinx exclusive content, including monthly highlights from our physician editor, D. Scott Cunningham, MD, PhD. We also feature clinical pearls from our Internal Medicine Physician Review. You can also get the latest updates on salary information, search available Pulmonology jobs, view upcoming Pulmonology and CME conferences and earn some extra cash by participating in Market Research opportunities.
Not yet an MDLinx.com Member??? Sign up now to gain access to MDLinx exclusive content, email alerts that keep you current on the latest medical news, research, and clinical articles on the topics of your choice, special communications and offers from MDLinx and our sponsors. Plus, you can now post your CV to the MDLinx Career Center to be viewed top medical recruiters who will help you find your next dream job.
Your Unread Messages in Pulmonology
See All >> Messages include industry-sponsored communications and special communications from MDLinx
Jill Baker
MDLinx Career Center
NPs and PAs play crucial role amid PCP shortage
Smartest Doc Challenge
MDLinx
Lung Cancer Clinical Pearls
MDLinx Reminder
MDLinx
Conference Center Upgraded with New Tools
MDLinx Top Read
MDLinx
Running from that pile of unread journals?
D Scott Cunningham MD, PhD
Site Editor, MDLinx
ASA reduces risk of ACS in hospitalized pneumonia patients
21 Phenotypic and genotypic properties of Microbacterium yannicii, a recently described multidrug resistant bacterium isolated from a lung transplanted patient with cystic fibrosis in France Full Text BMC Microbiology, May 6, 2013
22 Cystic Fibrosis Pulmonary Guidelines American Journal of Respiratory and Critical Care Medicine, May 2, 2013 Clinical Guideline
23 Staphylococcus aureus small-colony variants are independently associated with worse lung disease in children with cystic fibrosis Clinical Infectious Diseases, May 2, 2013 Review Article
24 Pseudomonas aeruginosa infection in cystic fibrosis lung disease and new perspectives of treatment: a review European Journal of Clinical Microbiology & Infectious Diseases, April 30, 2013 Review Article Clinical Article
25 Evidence of diminished FEV1 and FVC in 6-year-olds followed in the European cystic fibrosis patient registry, 2007-2009 Journal of Cystic Fibrosis, April 30, 2013 Clinical Article
26 The predictive potential of the sweat chloride test in cystic fibrosis patients with the G551D mutation Journal of Cystic Fibrosis, April 30, 2013 Clinical Article
27 Elevated levels of miR-145 correlate with SMAD3 down-regulation in Cystic Fibrosis patients Journal of Cystic Fibrosis, April 30, 2013 Clinical Article
28 Interstitial Pulmonary Fibrosis and Progressive Massive Fibrosis Related to Smoking Methamphetamine With Talc as Filler Full Text Respiratory Care, April 30, 2013
29 A Preliminary Evaluation of the Effectiveness of the Cystic Fibrosis Foundation Mentoring Program for Respiratory Care Full Text Respiratory Care, April 29, 2013 Clinical Article
30 Magnetic Resonance Imaging of Cystic Fibrosis Lung Disease Journal of Thoracic Imaging, April 29, 2013 Review Article
31 Lung Transplantation in Patients With Cystic Fibrosis Transplantation Proceedings, April 26, 2013 Review Article
32 FAK-Related Nonkinase Is a Multifunctional Negative Regulator of Pulmonary Fibrosis American Journal of Pathology, April 26, 2013 Clinical Article
33 Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis Current Opinion in Pharmacology , April 25, 2013 Review Article
34 A review of renal disease in cystic fibrosis Journal of Cystic Fibrosis, April 25, 2013 Review Article
35 A pilot study of the characterization of hepatic tissue strain in children with cystic-fibrosis-associated liver disease (CFLD) by acoustic radiation force impulse imaging Pediatric Radiology, April 25, 2013 Clinical Article
36 Correlation between respiratory cultures and sinus cultures in children with cystic fibrosis International Journal of Pediatric Otorhinolaryngology , April 24, 2013 Clinical Article
37 Physical activity levels of patients with cystic fibrosis hospitalised with an acute respiratory exacerbation Respiratory Medicine, April 23, 2013 Clinical Article
38 The effect of gastric juice on interleukin-8 production by cystic fibrosis primary bronchial epithelial cells Journal of Cystic Fibrosis, April 23, 2013 Clinical Article
39 Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis International Journal of Clinical Oncology, April 22, 2013 Clinical Article
40 Impact of exacerbations of cystic fibrosis on muscle strength Full Text Respiratory Research, April 22, 2013 Clinical Article
Using a murine mouse model of pneumonia, prolonged simvastatin therapy has a measureable effect on Streptococcus pneumoniae infection, but no effect on mortality. Mice were treated with simvastatin (1 mg/kg/d [low dose] or 10 mg/kg/d [high dose]) for 4 weeks, then infected with S. pneumoniae intrathecally. Mice treated with the high-dose regimen had less lung consolidation, decreased macrophage and neutrophil infiltration, decreased MCP-1, KC, and ICAM-1 production, and decreased bacterial titers in the blood 36 and 42 h post-infection. Despite these favorable physiologic effects, there was no effect on mortality compared to control mice treated with ampicillin 48 h post-infection.
Read the article summaryAs published in the European Journal of Internal Medicine, there were no mortalities in patients with community-acquired pneumonia (CAP) and low levels of D-dimer (< 500 ug/l). Of 147 patients in the study, D-dimer levels were elevated in those with severe CAP (2166 vs. 1630 ug/l), day 30-clinical failure (2228 vs. 1594 ug/l), early failure (2499 vs. 1669 ug/l), and non-survivors (3025 vs. 1680 ug/l). Importantly, D-dimer levels were not shown to be associated with clinical outcome based on multivariate analysis.
Read the article summaryAs published in the Journal of Infection, 114 of 981 (11.6%) of patients with pneumococcal pneumonia were bacteremic. Risk factors for bacteremia included immunosuppressants, age < 65 years, and diabetes mellitus. Patients with pneumococcal pneumonia and bacteria were at increased risk for mortality (28.6% vs. 8.5%). The combination of bacteremia, cerebrovascular disease, and septic shock had a strong association with mortality in patients with pneumococcal pneumonia.
Read the article summary1 Physical activity levels of patients with cystic fibrosis hospitalised with an acute respiratory exacerbation Respiratory Medicine, April 23, 2013
2 Lung Transplantation in Patients With Cystic Fibrosis Transplantation Proceedings, April 26, 2013 Review Article
3 Beta-blocker management of refractory hemoptysis in cystic fibrosis: a novel treatment approach Therapeutic Advances in Respiratory Disease, April 1, 2013 Review Article
4 Development and Validation of a Cystic Fibrosis Patient and Family Member Experience of Care Survey Quality Management in Health Care , April 11, 2013
5 Update on cystic fibrosis-related diabetes Journal of Cystic Fibrosis, April 19, 2013 Review Article
6 Tobramycin is a suppressor of premature termination codons Journal of Cystic Fibrosis, April 4, 2013
7 Factors associated with FEV1 decline in cystic fibrosis: analysis of the data of the ECFS Patient Registry European Respiratory Journal , April 22, 2013
8 The current position of surgical lung biopsy in the diagnosis of idiopathic pulmonary fibrosis Respiratory Research, April 16, 2013 Free full text Review Article
9 Magnetic Resonance Imaging of Cystic Fibrosis Lung Disease Journal of Thoracic Imaging, April 29, 2013 Review Article
10 Automated quantification of radiologic patterns predicts survival in idiopathic pulmonary fibrosis European Respiratory Journal , April 8, 2013
11 Effect of supervised training on FEV1 in cystic fibrosis: A randomised controlled trial Journal of Cystic Fibrosis, April 16, 2013
12 Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non–Cystic Fibrosis Bronchiectasis: The BAT Randomized Controlled Trial JAMA, March 27, 2013 Evidence Based Medicine
13 Pulmonary hypertension is a mild comorbidity in end-stage cystic fibrosis patients The Journal of Heart and Lung Transplantation, April 15, 2013
14 A review of renal disease in cystic fibrosis Journal of Cystic Fibrosis, April 25, 2013 Review Article
15 Approach to acute exacerbation of idiopathic pulmonary fibrosis Annals of Thoracic Medicine, April 4, 2013 Free full text Review Article
16 Interventions for the eradication of methicillin-resistant Staphylococcus aureus (MRSA) in people with cystic fibrosis Cochrane Reviews, March 19, 2013 Evidence Based Medicine
17 Long-term multicentre randomised controlled study of high frequency chest wall oscillation versus positive expiratory pressure mask in cystic fibrosis Thorax, February 21, 2013
18 A pulmonary exacerbation risk score among cystic fibrosis patients not receiving recommended care Pediatric Pulmonology, January 9, 2013
19 Pathogenesis, current treatments and future directions for idiopathic pulmonary fibrosis Current Opinion in Pharmacology , April 25, 2013 Review Article
20 A Preliminary Evaluation of the Effectiveness of the Cystic Fibrosis Foundation Mentoring Program for Respiratory Care Respiratory Care, April 29, 2013 Free full text
Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicine more
Register now to view all the MDLinx contents (FREE)!
Login
Stay current - Media Tool
♦ Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More ♦
♦ Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More ♦
Close